000 01835 a2200505 4500
005 20250514053731.0
264 0 _c20030429
008 200304s 0 0 eng d
022 _a0014-2972
024 7 _a10.1046/j.1365-2362.2003.01105.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNaoumova, R P
245 0 0 _aTreatment with atorvastatin alters the ratio of interleukin-12/interleukin-10 gene expression [corrected].
_h[electronic resource]
260 _bEuropean journal of clinical investigation
_cJan 2003
300 _a88-91 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAnticholesteremic Agents
_xpharmacology
650 0 4 _aAtorvastatin
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHeptanoic Acids
_xpharmacology
650 0 4 _aHumans
650 0 4 _aHyperlipoproteinemia Type II
_xblood
650 0 4 _aInterleukin-10
_xbiosynthesis
650 0 4 _aInterleukin-12
_xbiosynthesis
650 0 4 _aInterleukin-12 Subunit p35
650 0 4 _aLeukocytes, Mononuclear
_ximmunology
650 0 4 _aLipids
_xblood
650 0 4 _aMale
650 0 4 _aMevalonic Acid
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aProtein Subunits
_xbiosynthesis
650 0 4 _aPyrroles
_xpharmacology
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSingle-Blind Method
700 1 _aPatel, D D
700 1 _aO'Neill, F H
700 1 _aThompson, G R
700 1 _aKnight, B L
773 0 _tEuropean journal of clinical investigation
_gvol. 33
_gno. 1
_gp. 88-91
856 4 0 _uhttps://doi.org/10.1046/j.1365-2362.2003.01105.x
_zAvailable from publisher's website
999 _c12296548
_d12296548